Wikidata

(Q62030750)

English

Study to Evaluate the Safety of Intravitreal APL-2 in Patients Diagnosed With Geographic Atrophy

clinical trial

In more languages

Statements

title
A 24-Month Phase Ib Multi-Center, Open Label, Single Arm Study to Evaluate the Safety of Intravitreal APL-2 Therapy in Patients Diagnosed With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (English)
0 references
medical condition
atrophy
0 references
start time
5 November 2018
0 references
end time
31 December 2020
0 references
number of participants
12
0 references
minimum age
60 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62030750&oldid=2077281089"